Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-01-30

Clinical Trial Update: Escitalopram and the Risk of Serious Adverse Events

View source ↗

Summary

Clinical trial update evaluating the risk of serious adverse events with escitalopram in elderly outpatients with chronic kidney disease; the study status is co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Escitalopram (escitalopram)

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Chronic Kidney Disease (CKD), Elderly | Status: COMPLETED